Skip to main content
    S

    Sellas Life Sciences Group Inc (SLS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.47
    -0.39 (-4.96%)

    Market Cap: $1.60B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sellas Life Sciences Group Inc (SLS) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sellas Life Sciences Group (SLS) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Sellas Life Sciences Group reported EPS of -$0.05, in line with the -$0.05 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(20/38)
    Avg Surprise
    -14.29%

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.05
    Range-$0.05 - -$0.05
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A

    Next Report

    SLS has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 38 quarters below that had an estimate, SLS beat 20, missed 15 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 377.78% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.05-$0.05-$0.05 - -$0.050.00%In lineN/A10 up, 0 downNov 12, 2026N/A
    Jun 30, 2026-$0.05-$0.04-$0.05 - -$0.04-25.00%MissN/A21 up, 1 downAug 11, 2026N/A
    Mar 31, 2026-$0.05-$0.07-$0.08 - -$0.04+30.43%BeatN/A21 up, 0 downMay 12, 2026N/A
    Dec 31, 2025-$0.05-$0.06-$0.09 - -$0.05+16.67%BeatN/A31 up, 0 downMar 19, 2026N/A
    Sep 30, 2025-$0.06-$0.08-$0.10 - -$0.06+25.00%BeatN/A30 up, 0 downNov 12, 2025N/A
    Jun 30, 2025-$0.07-$0.08-$0.10 - -$0.06+12.50%BeatN/A30 up, 0 downAug 12, 2025N/A
    Mar 31, 2025-$0.07-$0.11-$0.12 - -$0.09+36.36%BeatN/A31 up, 0 downMay 13, 2025N/A
    Dec 31, 2024-$0.08-$0.11-$0.12 - -$0.09+25.02%BeatN/A32 up, 1 downMar 20, 2025N/A
    Sep 30, 2024-$0.10-$0.13-$0.15 - -$0.11+23.08%BeatN/A20 up, 0 downNov 13, 2024N/A
    Jun 30, 2024-$0.13-$0.17-$0.17 - -$0.16+23.53%BeatN/A20 up, 0 downAug 13, 2024N/A
    Mar 31, 2024-$0.21-$0.16-$0.16 - -$0.16-31.25%MissN/A10 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.25$0.09-$0.27 - $0.12-377.78%MissN/A40 up, 0 downMar 28, 2024N/A
    Sep 30, 2023-$0.33$0.02-$0.32 - $0.15N/AN/AN/A40 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$0.31-$0.35-$0.40 - -$0.29+11.43%BeatN/A40 up, 0 downAug 10, 2023N/A
    Mar 31, 2023-$0.47-$0.29-$0.29 - -$0.29-62.07%MissN/A30 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$0.43-$0.32-$0.36 - -$0.26-34.38%MissN/A30 up, 0 downMar 16, 2023N/A
    Sep 30, 2022-$0.34-$0.39-$0.42 - -$0.36+12.82%BeatN/A30 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$0.42-$0.37N/A-13.51%MissN/AN/A0 up, 0 downAug 11, 2022N/A
    Mar 31, 2022-$0.42-$0.42N/A0.00%In lineN/A10 up, 0 downMay 12, 2022$1.00M
    Dec 31, 2021-$0.42-$0.41-$0.45 - -$0.34-2.44%MissN/A30 up, 0 downMar 31, 2022N/A
    Sep 30, 2021-$0.45-$0.34-$0.43 - -$0.30-32.35%MissN/A31 up, 0 downNov 12, 2021N/A
    Jun 30, 2021-$0.30-$0.39-$0.52 - -$0.29+23.08%BeatN/A3N/AAug 12, 2021$1.90M
    Mar 31, 2021-$0.16-$0.36-$0.36 - -$0.18+55.56%BeatN/A2N/AMay 13, 2021$5.70M
    Dec 31, 2020-$0.28-$0.28-$0.36 - -$0.190.00%In lineN/A2N/AMar 23, 2021$1.90M
    Sep 30, 2020-$0.53-$0.34-$0.34 - -$0.27-55.88%MissN/A2N/ANov 13, 2020N/A
    Jun 30, 2020-$0.63-$0.64-$0.64 - -$0.64+1.56%BeatN/A1N/AAug 13, 2020N/A
    Mar 31, 2020-$0.63-$0.68N/A+7.35%BeatN/AN/AN/AMay 14, 2020N/A
    Dec 31, 2019-$1.54-$0.72-$0.87 - -$0.58-113.89%MissN/A2N/AMar 13, 2020N/A
    Sep 30, 2019-$0.96-$1.00-$1.00 - -$1.00+4.00%BeatN/A1N/ANov 14, 2019N/A
    Jun 30, 2019-$6.19-$9.00-$9.00 - -$9.00+31.22%BeatN/A1N/AAug 14, 2019N/A
    Mar 31, 2019-$9.71-$10.25-$11.50 - -$9.00+5.27%BeatN/A2N/AMay 15, 2019N/A
    Dec 31, 2018-$8.50-$11.75-$15.50 - -$8.00+27.66%BeatN/A2N/AMar 22, 2019N/A
    Sep 30, 2018-$26.50-$20.25-$20.50 - -$18.00-30.86%MissN/A2N/ANov 15, 2018N/A
    Jun 30, 2018-$63.00-$51.50-$54.00 - -$49.00-22.33%MissN/A2N/AAug 15, 2018N/A
    Mar 31, 2018-$83.50-$46.50-$46.50 - -$46.50-79.57%MissN/A1N/AApr 13, 2018N/A
    Dec 31, 2017-$49.50-$1.06N/AN/AN/AN/AN/AN/AMar 15, 2018N/A
    Sep 30, 2017-$30.00-$225.00N/A+86.67%BeatN/AN/AN/ANov 9, 2017N/A
    Jun 30, 2017-$330.00-$270.00N/A-22.22%Miss-127.5%N/AN/AAug 14, 2017N/A
    Mar 31, 2017-$675.00-$330.00N/A-104.55%MissN/AN/AN/AMay 10, 2017N/A
    Dec 31, 2016-$735.00-$780.00N/A+5.77%BeatN/AN/AN/AMar 15, 2017N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.25, after -$0.52 the year before. It was -$3,135.00 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.25N/A
    Dec 31, 2024-$0.52N/A
    Dec 31, 2023-$1.36N/A
    Dec 31, 2022-$1.61N/A
    Dec 31, 2021-$1.33N/A
    Dec 31, 2020-$2.07N/A
    Dec 31, 2019-$18.40N/A
    Dec 31, 2018-$181.50N/A
    Dec 31, 2017-$1,084.50N/A
    Dec 31, 2016-$3,135.00N/A

    Frequently Asked Questions About SLS

    When is Sellas Life Sciences Group's next earnings date?

    Sellas Life Sciences Group's next earnings report is expected for Mar 17, 2027.

    Did SLS beat earnings estimates last quarter?

    Sellas Life Sciences Group reported EPS of -$0.05 for the quarter ended Sep 30, 2026, in line with the -$0.05 estimate.

    What EPS do analysts expect from SLS next quarter?

    The consensus EPS estimate for Sellas Life Sciences Group for the quarter ending Dec 31, 2026 is -$0.05 from 3 analysts, with estimates from -$0.05 to -$0.05.

    How often does SLS beat earnings estimates?

    Sellas Life Sciences Group beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +15.12%.